Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-18, Stock:ABBV, The news for the past five days is as follows:
2019-11-11: NEWS1: Top Research Reports for Toyota, Netflix & AbbVie.NEWS2: Mario Gabelli Continues to Buy AbbVie, Axalta.NEWS3: AbbVie Eyes Approval for Imbruvica+Rituxan in First-Line CLL.
2019-11-12: NEWS1: AbbVie Sells $30 Billion of Bonds to Fund Allergan Acquisition.NEWS2: US Indexes End the Day Higher Tuesday.NEWS3: Corporations Pile Into Bond Market as Borrowing Costs Drop.NEWS4: New Positive Data for RINVOQ™ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting.NEWS5: The Zacks Analyst Blog Highlights: Toyota, Netflix, AbbVie, Gilead and Fiserv.NEWS6: AbbVie Rises 3%.NEWS7: AbbVie sells $30bn of bonds to finance Allergan takeover.NEWS8: AbbVie readies $30bn bond sale to finance Allergan takeover.NEWS9: AbbVie Eyes Up to $28 Billion Bond Sale to Finance Allergan Deal: Report.NEWS10: AbbVie readies $27bn bond sale to finance Allergan takeover.
2019-11-13: NEWS1: Should Investors Add Johnson & Johnson Stock to Their Shopping Lists?.NEWS2: AbbVie Takes on Debt to Buy Allergan.NEWS3: AbbVie’s $30 Billion Bond Sale Was Wall Street’s Biggest This Year.NEWS4: Abbott Labs Chooses an Insider to Be Its New CEO.NEWS5: Cash Stashes Dwindle as Markets Crest and Powell Speaks: Market Recon.NEWS6: AbbVie Prices $30 Billion of Senior Unsecured Notes.
2019-11-14: NEWS1: Seth Klarman Exits Allergan, Buys 3 New Positions in 3rd Quarter.NEWS2: Exicures shares up on Allergan partnership.NEWS3: Beware of Runs on Bond Funds.NEWS4: AbbVie Sold $30 Billion in Bonds, and Two More Numbers to Know.
2019-11-15: NEWS1: Pharma Stock Roundup: MRK, GSK, ABBV, LLY's Pipeline & Regulatory Updates.NEWS2: 4 Big Drugmakers to Bet on After a Great Earnings Season.NEWS3: Credit market fears of downgrades have not materialised.

Answer: Rise